NeutriSci International Inc. (TSXV:NU)


NeutriSci International Inc. is a Vancouver-based pharmaceutical company that operates as a drug manufacturer in the healthcare sector. NeutriSci International is specialized in the development, formulation, manufacturing and marketing of nutraceutical products to its business partners.

Nutraceutical solutions are pharmaceutical alternatives that supplements diet and helps in disease prevention/ treatment, thus claims to provide physiological benefits. These are also called bioceutical products. The company’s product portfolio includes Neuenergy and BluScience.

The company implements its proprietary Cryolization Technology that incorporates natural ingredients allowing its partners to innovate product solutions. The patent pending IP and technology efficiently release the ingredients into the bloodstream.

This method is effective in minimizing waste and hence, requires less ingredients. In addition, NeutriSci provide various solutions and expert assistance to clients to produce quality medicinal products for the market. It offers the following services to its clientele:

• Expert advice and support

• Strategic and operational consulting

• Formulation of products

• Production

• Quality control

• Packaging

• Warehousing

• Shipping

This way, the company effectively delivers innovative product solutions. NeutriSci International has an 8,000 square feet primary facility in Las Vegas and ancillary facilities covering a total area of 12,000 square feet in Nevada Washington and Florida.

The company has 15 production machines, a full research and development laboratory, and other equipment such as mixers, grinders and a heat-sealing tunnel. It also has beverage, food, and nutraceutical packaging equipment.

With all its production assets, the company can produce a minimum of 648 kilograms of product output per day. The daily production output is expected to be 540,000 tablets and 195,000 sachets.

NeutriSci International’s TSX Venture Exchange stock ticker is NU. It is also listed on the Frankfurt Stock Exchange and OTCQB market under the trading symbols 1N9 and NRXCF, respectively. The company is focused on cobranding, private label opportunities and contract production services to build sustainable sales models with various retail operators in mass market and supermarket, convenience and chain drug stores in the United States, Europe, South America and Asia.

Contact Information

company address 1600 - 609 Granville Street Vancouver, B.C. V7Y 1C3

company phone778 331-8505

company email[email protected]

company website

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK